As a heterogeneous disease, NSCLC may have multiple histologic subtypes that harbor disparate mutational profiles such as EGFR, ALK, and KRAS mutations, which are the known predominant genetic drivers (19). This evidence concerns the gene ALK and non-small cell lung carcinoma.